إعلان
إعلان
BIO
Bio-Rad Laboratories, Inc.Class A
325.50
USDبرعاية
+3.30
+1.02%
٠٦ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
325.75
+0.25
+0.08%
تقارير أرباح BIO
النسبة الإيجابية المفاجئة
BIO تفوق 29 من 40 آخر التقديرات.
73%
التقرير التالي
بيانات التقرير القادم
١١ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$705.51M
/$2.77
التغير الضمني من Q3 25 (Revenue/ EPS)
+8.04%
/+23.11%
التغير الضمني من Q4 24 (Revenue/ EPS)
+5.69%
/-4.48%
Bio-Rad Laboratories, Inc.Class A earnings per share and revenue
On ٢٩ أكتوبر ٢٠٢٥, BIO reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 1.95 USD, resulting in a 15.74% surprise. Revenue reached 653.00 مليون, compared to an expected 657.81 مليون, with a -0.73% difference. The market reacted with a -4.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of 2.77 USD, with revenue projected to reach 705.51 مليون USD, implying an زيادة of 23.11% EPS, and زيادة of 8.04% in Revenue from the last quarter.
الأسئلة الشائعة
What were Bio-Rad Laboratories, Inc.Class A's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bio-Rad Laboratories, Inc.Class A reported EPS of $2.25, beating estimates by 15.74%, and revenue of $653.00M, -0.73% below expectations.
How did the market react to Bio-Rad Laboratories, Inc.Class A's Q3 2025 earnings?
The stock price moved down -4.65%, changed from $319.47 before the earnings release to $304.61 the day after.
When is Bio-Rad Laboratories, Inc.Class A expected to report next?
The next earning report is scheduled for ١١ فبراير ٢٠٢٦.
What are the forecasts for Bio-Rad Laboratories, Inc.Class A's next earnings report?
Based on 6
المحللين, Bio-Rad Laboratories, Inc.Class A is expected to report EPS of $2.77 and revenue of $705.51M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان